We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
The Business Café will open its first café in early 2018 and thereafter become a network of coffee shops for business people, uniting business friendship in towns across the UK and beyond.
days to go: Expired investment: £94,170
Planks is a ski brand producing professional performance ski apparels & streetwear. Planks has a list of leading stockists including Snow&Rock, ASOS and Ellis Brigham. The company also has four retail stores and cafe in some of Europe’s top ski resorts including Val d'lsere, Tignes, Morzine and Meribel. It has witnessed strong YoY growth in the last 12months (EBITDA -£581k) because of its strong followings amongst travel agencies. The company has received 15000+ online order from 15 countries in the last 12 months. The company will use the funds to expand its business in each resort globally.
days to go: Expired investment: £343,470
Stagedoor is a new generation theatre guide and hassle-free booking platform. It is London's first discovery-led theatre application which makes purchasing theatre tickets easy. Stagedoor is the official application for the Camden Fringe and VAULT Festival, and currently, it's having discussions to bring Stagedoor to the Edinburgh Festival. The user growth of the company has increased and reached 53,000 downloads. Furthermore, it has raised 730K from angel investors & an EU innovation grant. Stagedoor will use the funds raised in growing its user base and in improving its application and website.
days to go: Expired investment: £193,450
An innovative and flourishing brewery, with music as its main source of inspiration. Signature Brew has won multiple awards for their beers, including the SIBA for Brewery Business of the Year 2018. The company is passionate abut serving brews alongside bands; their collaborations include Foo Fighters, Frank Turner, Mastodon and alt-J. Signature Brew's core beers are enjoyed nationwide, such as Studio Pilsner and Roadie. Their products are sold in bars, pubs and supermarkets, as well as at venues and festivals. Over the past 3 years, the company has seen YoY growth of 78%, with revenues of £1.13m in the last 12 months. Signature Brew is currently producing over 1m pints per year and is now seeking investment to increase capacity. The company intends to move its services to a nearly site in East London and develop a new brew house. This will result in capacity increasing by three-fold. In addition, Signature Brew intends to open two more taprooms to host events and showcase their beers.
days to go: Expired investment: £567,030
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph